Gunnar Brinkmalm

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

Thomas K. Karikari, Tharick A. Pascoal, Nicholas J. Ashton et al. · The Lancet Neurology · 2020 · 1.3K citations

Alzheimer's Disease, Dementia, Prospective Cohorts +11

Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology

Nicholas J. Ashton, Tharick A. Pascoal, Thomas K. Karikari et al. · Acta Neuropathologica · 2021 · 668 citations · Full text

Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease

Hlin Kvartsberg, Flora H. Duits, Martin Ingelsson et al. · Alzheimer s & Dementia · 2014 · 359 citations

Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer’s disease

Erik Portelius, Nenad Bogdanović, Mikael K. Gustavsson et al. · Acta Neuropathologica · 2010 · 335 citations · Full text

Neuroimaging Biomarkers, Neurodegenerative Diseases, Alzheimer's Disease +11

Enrichment of glycopeptides for glycan structure and attachment site identification

Jonas Nilsson, Ulla Rüetschi, Adnan Halim et al. · Nature Methods · 2009 · 322 citations

Biochemistry, Natural Sciences, Peptide Library +8